BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kobayashi M, Higuchi S, Ide M, Nishikawa S, Fukami T, Nakajima M, Yokoi T. Th2 cytokine-mediated methimazole-induced acute liver injury in mice: Methimazole-induced hepatotoxicity. J Appl Toxicol 2012;32:823-33. [DOI: 10.1002/jat.2731] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sasaki E, Matsuo K, Iida A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. A Novel Mouse Model for Phenytoin-Induced Liver Injury: Involvement of Immune-Related Factors and P450-Mediated Metabolism. Toxicological Sciences 2013;136:250-63. [DOI: 10.1093/toxsci/kft184] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
2 Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats. Drug Metab Dispos 2015;43:958-68. [DOI: 10.1124/dmd.115.063370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sasaki E, Iida A, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors. Exp Toxicol Pathol 2016;68:27-38. [PMID: 26391595 DOI: 10.1016/j.etp.2015.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Xie Z, Chen E, Ouyang X, Xu X, Ma S, Ji F, Wu D, Zhang S, Zhao Y, Li L. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury. J Proteome Res 2019;18:2514-24. [PMID: 31002254 DOI: 10.1021/acs.jproteome.9b00047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
5 Sasaki E, Iwamura A, Tsuneyama K, Fukami T, Nakajima M, Kume T, Yokoi T. Role of cytochrome P450-mediated metabolism and identification of novel thiol-conjugated metabolites in mice with phenytoin-induced liver injury. Toxicology Letters 2015;232:79-88. [DOI: 10.1016/j.toxlet.2014.10.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Uematsu Y, Akai S, Tochitani T, Oda S, Yamada T, Yokoi T. MicroRNA-mediated Th2 bias in methimazole-induced acute liver injury in mice. Toxicol Appl Pharmacol 2016;307:1-9. [PMID: 27421576 DOI: 10.1016/j.taap.2016.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
7 Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Iwaku K, Yoshihara A, Watanabe N, Sugino K, Ito K. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves’ Disease in Japan. Thyroid 2019;29:1390-8. [DOI: 10.1089/thy.2019.0045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Heidari R, Niknahad H, Jamshidzadeh A, Eghbal MA, Abdoli N. An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv Pharm Bull 2015;5:1-11. [PMID: 25789213 DOI: 10.5681/apb.2015.001] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
9 Shirai Y, Oda S, Makino S, Tsuneyama K, Yokoi T. Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis. Lab Invest 2017;97:833-42. [PMID: 28263289 DOI: 10.1038/labinvest.2017.22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
10 Takai S, Higuchi S, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice: Flucloxacillin-induced liver injury. J Appl Toxicol 2015;35:142-51. [DOI: 10.1002/jat.3002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
11 Akai S, Uematsu Y, Tsuneyama K, Oda S, Yokoi T. Kupffer cell-mediated exacerbation of methimazole-induced acute liver injury in rats: Methimazole-induced liver injury in rats. J Appl Toxicol 2016;36:702-15. [DOI: 10.1002/jat.3202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
12 Akai S, Oda S, Yokoi T. Strain and interindividual differences in lamotrigine-induced liver injury in mice. J Appl Toxicol 2019;39:451-60. [PMID: 30325050 DOI: 10.1002/jat.3736] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Bonkovsky HL, Barnhart HX, Foureau DM, Steuerwald N, Lee WM, Gu J, Fontana RJ, Hayashi PJ, Chalasani N, Navarro VM, Odin J, Stolz A, Watkins PB, Serrano J; US Drug-Induced Liver Injury Network and the Acute Liver Failure Study Group. Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One 2018;13:e0206389. [PMID: 30359443 DOI: 10.1371/journal.pone.0206389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
14 Candellone A, Saettone V, Badino P, Girolami F, Radice E, Bergero D, Odore R, Meineri G. Management of Feline Hyperthyroidism and the Need to Prevent Oxidative Stress: What Can We Learn from Human Research? Antioxidants (Basel) 2021;10:1496. [PMID: 34573128 DOI: 10.3390/antiox10091496] [Reference Citation Analysis]
15 Takai S, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism: Mechanism of amiodarone-induced liver injury. J Appl Toxicol 2016;36:35-47. [DOI: 10.1002/jat.3141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
16 Heidari R, Ahmadi F, Rahimi HR, Azarpira N, Hosseinzadeh M, Najibi A, Niknahad H. Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice. Drug Chem Toxicol 2019;42:615-23. [PMID: 29722569 DOI: 10.1080/01480545.2018.1459668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Wang X, Zhang L, Jiang Z. T-helper cell-mediated factors in drug-induced liver injury. J Appl Toxicol. 2015;35:695-700. [PMID: 25752261 DOI: 10.1002/jat.3115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 Matsuo K, Sasaki E, Higuchi S, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury. Toxicol Lett 2014;224:215-24. [PMID: 24184165 DOI: 10.1016/j.toxlet.2013.10.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
19 Kumar N, Surani S, Udeani G, Mathew S, John S, Sajan S, Mishra J. Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. Life Sci 2021;278:119544. [PMID: 33945827 DOI: 10.1016/j.lfs.2021.119544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Proctor WR, Chakraborty M, Fullerton AM, Korrapati MC, Ryan PM, Semple K, Morrison JC, Berkson JD, Chea LS, Yang Q, Li AP, Spolski R, West EE, Rochman Y, Leonard WJ, Bourdi M, Pohl LR. Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology 2014;60:1741-52. [PMID: 24723460 DOI: 10.1002/hep.27169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Roth AD, Lee MY. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. Biomed Res Int 2017;2017:9176937. [PMID: 28133614 DOI: 10.1155/2017/9176937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
22 Jia R, Oda S, Yokoi T. Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in mice. Toxicology 2020;443:152560. [PMID: 32795494 DOI: 10.1016/j.tox.2020.152560] [Reference Citation Analysis]
23 Heidari R, Niknahad H, Jamshidzadeh A, Abdoli N. Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin Mol Hepatol 2014;20:237-48. [PMID: 25320726 DOI: 10.3350/cmh.2014.20.3.237] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
24 Watanabe K, Oda S, Matsubara A, Akai S, Yokoi T. Establishment and characterization of a mouse model of rhabdomyolysis by coadministration of statin and fibrate. Toxicology Letters 2019;307:49-58. [DOI: 10.1016/j.toxlet.2019.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Tu C, Niu M, Wei AW, Tang JF, Zhang L, Jing J, Xiao XH, Wang JB. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. J Inflamm Res 2021;14:645-55. [PMID: 33692634 DOI: 10.2147/JIR.S299892] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pires DA, Marques PE, Pereira RV, David BA, Gomides LF, Dias AC, Nunes-Silva A, Pinho V, Cara DC, Vieira LQ, Teixeira MM, Menezes GB. Interleukin-4 deficiency protects mice from acetaminophen-induced liver injury and inflammation by prevention of glutathione depletion. Inflamm Res 2014;63:61-9. [PMID: 24100592 DOI: 10.1007/s00011-013-0671-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]